| 000 | 01563 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513112219.0 | ||
| 264 | 0 | _c19970515 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a0931-041X | ||
| 024 | 7 |
_a10.1007/s004670050224 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKonrad, M | |
| 245 | 0 | 0 |
_aHLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. _h[electronic resource] |
| 260 |
_bPediatric nephrology (Berlin, Germany) _cFeb 1997 |
||
| 300 |
_a16-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 |
_aAlkylating Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aChlorambucil _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDNA _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHLA-DR7 Antigen _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xblood |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSteroids _xtherapeutic use |
| 700 | 1 | _aMytilineos, J | |
| 700 | 1 | _aRuder, H | |
| 700 | 1 | _aOpelz, G | |
| 700 | 1 | _aSchärer, K | |
| 773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 11 _gno. 1 _gp. 16-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s004670050224 _zAvailable from publisher's website |
| 999 |
_c9024016 _d9024016 |
||